Literature DB >> 18674928

Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.

Peter L Roberts1.   

Abstract

Virus inactivation by solvent/detergent treatment using 0.3% tri-n-butyl phosphate and 1% Triton X-100 in the high purity factor VIII concentrate Replenate has been investigated. A wide range of model enveloped viruses were confirmed to be inactivated by >4 to >6 log after 30 min at 22 degrees C under standard conditions. Using Sindbis as a representative enveloped virus, the effect of various parameters on the inactivation process was tested. Virus inactivation was confirmed to be effective in different batches of product and was not influenced by changing the process conditions with regard to protein and salt concentration or pH. Virus inactivation was effective even at a temperature as low as 4-5 degrees C. Although solvent/detergent concentration was the most critical parameter, a concentration as low as 0.15% TnBP/0.5% Triton X-100 was still completely effective. At a lower concentration an extended incubation period was required. These studies demonstrate the robustness of this solvent/detergent procedure based on Triton X-100 and allow suitable process limits to be set for this manufacturing step.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674928     DOI: 10.1016/j.biologicals.2008.06.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  10 in total

1.  Sample Buffer Containing Guanidine-Hydrochloride Combines Biological Safety and RNA Preservation for SARS-CoV-2 Molecular Diagnostics.

Authors:  Lisa Weidner; Sandra Laner-Plamberger; David Horner; Charlotte Pistorius; Jennifer Jurkin; Michael Karbiener; Elisabeth Schistal; Thomas R Kreil; Christof Jungbauer
Journal:  Diagnostics (Basel)       Date:  2022-05-10

2.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

3.  A Simple Modification to the Mosquito Homogenization Protocol Safely Inactivates West Nile Virus and Allows Virus Detection by the Rapid Analyte Measurement Platform (RAMP®) ASSAY.

Authors:  Kristen L Burkhalter; Brad J Biggerstaff; Kalanthe Horiuchi; Harry M Savage
Journal:  J Am Mosq Control Assoc       Date:  2016-06       Impact factor: 0.917

4.  Development and evaluation of an indirect enzyme-linked immunosorbent assay for serological detection of Schmallenberg virus antibodies in ruminants using whole virus antigen.

Authors:  Katarina Näslund; Gunilla Blomqvist; Caroline Vernersson; Stéphan Zientara; Emmanuel Bréard; Jean F Valarcher
Journal:  Acta Vet Scand       Date:  2014-12-05       Impact factor: 1.695

5.  Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis.

Authors:  Yanyan Liu; Okechukwu C Ndumnego; Tingting Chen; Ryung S Kim; Elizabeth R Jenny-Avital; Thumbi Ndung'u; Douglas Wilson; Jacqueline M Achkar
Journal:  Pathogens       Date:  2018-02-27

6.  Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.

Authors:  Haibin Luo; Yuling Li; David Robbins; Sheau-Chiann Wang; Guoling Xi; Matthew Cox; Simone M Nicholson; Chenghong Wei; Timothy M Pabst; William K Wang
Journal:  Biotechnol Prog       Date:  2021-01-06

Review 7.  Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Authors:  Simon Elveborg; Vanessa M Monteil; Ali Mirazimi
Journal:  Pathogens       Date:  2022-02-19

8.  Quantitative Proteomic Analysis of Chikungunya Virus-Infected Aedes aegypti Reveals Proteome Modulations Indicative of Persistent Infection.

Authors:  Yingjun Cui; Pei Liu; Brian P Mooney; Alexander W E Franz
Journal:  J Proteome Res       Date:  2020-05-21       Impact factor: 4.466

9.  Validation of Inactivation Methods for Arenaviruses.

Authors:  Silke Olschewski; Anke Thielebein; Chris Hoffmann; Olivia Blake; Jonas Müller; Sabrina Bockholt; Elisa Pallasch; Julia Hinzmann; Stephanie Wurr; Neele Neddersen; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

10.  Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification.

Authors:  Julia Scheffel; Sara Kanje; Jesper Borin; Sophia Hober
Journal:  MAbs       Date:  2019-09-17       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.